Developer docs
API playgroundTry for free, no card

Search company profiles

Quantify Research

Full company profile

uuid000dgzj

Namestring
Quantify Research
Legal namestring
Quantify Research AB
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Quantify Research is a privately held health economics and outcomes research (HEOR) consultancy founded in 2011 in Stockholm, Sweden, now operating as part of the Athagoras Group. The company delivers health economic modelling, real-world evidence generation, market access strategy, evidence review and synthesis, and medical writing services to large pharmaceutical companies, medical device manufacturers, government bodies, and academic institutions across Europe and North America. Its core differentiator is access to Nordic administrative and disease-specific registries providing population-level coverage of approximately 26 million inhabitants across Sweden, Denmark, Norway, and Finland, with the ability to link patient-level data across primary care, hospitalizations, prescriptions, socioeconomics, labs, EHRs, and PROMs. Quantify maintains disease-specific research platforms in asthma (NORDSTAR, covering 3 million+ patients), cardiovascular disease, chronic liver disease (HERALD, with Karolinska Institutet), Parkinson's disease, psoriasis/psoriatic arthritis, and oncology.

Quantify Research operates a portfolio of proprietary software tools built on top of this data and consulting expertise. These include Qniform (a proprietary common data model for cross-Nordic data harmonization and validation), Q-tracker (a Power BI-based interactive visualization and analysis tool), Qfront (a cloud-based web application platform that converts Excel-based health economic models into interactive multi-user web apps), Qmodel (a free, generic Excel-based cost-effectiveness model for oncology), and Quantify Data Explorer (an R Shiny-based epidemiological visualization tool). The company combines 50% PhD-level talent with active academic affiliations to Karolinska Institutet, holds a track record of 200+ completed observational data projects and 100+ peer-reviewed publications, and reports data access turnarounds as short as two weeks.

The business model is professional services revenue generated through quote-based B2B engagements, augmented by productized software and disease-specific data platforms that support reuse across pharma accounts. Quantify operates from offices in Stockholm (headquarters), Copenhagen, Helsinki, Oslo, and Chandigarh (via wholly-owned subsidiary Quantify HEOR Private Limited), with a 11-50 employee base. Distribution is primarily enterprise direct sales supplemented by scientific-community marketing through ISPOR, EASL, EHA, Eurospine, and similar conferences, alongside an active peer-reviewed publication program that drives inbound enterprise interest. No external funding rounds are disclosed.

Short descriptiontext

Quantify Research is a Stockholm-based HEOR consultancy providing health economic modelling, real-world evidence, and market access services to pharmaceutical, medical device, government, and academic clients, leveraging proprietary access to Nordic registry data covering ~26 million inhabitants and a portfolio of in-house analytics software tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health economics consulting, real-world evidence, market access services, outcomes research, pharmaceutical analytics
Industry4 codes
PRIMARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAJANAM
Data Linkage, Registries & Longitudinal Cohort Surveillance
SECONDARYHLACAIAE
Healthcare Data Quality, Profiling & Observability
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAHAC
Quality Measurement, Reporting & Benchmarking (HEDIS/Stars/CQM)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
NAICS code2 codes
  • Other Scientific and Technical Consulting Services54169
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
Product category
Health Economics & Outcomes Research Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Health Economics & Outcomes Research Consultancy
TypeProfessional Services
Description

Professional services revenue generated through consulting engagements with pharmaceutical companies, biotech firms, healthcare organizations, and government bodies. Services include economic modelling, evidence generation, market access strategy, and biostatistics analysis.

quantifyresearch.com
2Real-World Evidence Studies
TypeProfessional Services
Description

RWE generation services using Nordic registry data for clinical, economic, and regulatory decision-making purposes across product lifecycle.

quantifyresearch.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Quantify Research is a health economics and outcomes research consultancy that delivers health economic modelling, Nordic market access strategy, real-world evidence generation from Nordic registries, evidence review and synthesis, and medical writing for pharmaceutical, biotech, medical device, and government clients. The firm complements its consulting services with proprietary software (Qniform, Q-tracker, Qfront, Qmodel, Quantify Data Explorer) and disease-specific real-world data platforms covering asthma, cardiovascular disease, chronic liver disease, Parkinson's disease, psoriasis, and oncology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 200+ observational data projects completed
+3 more records
Product overview1 text field

Quantify Research offers a portfolio of software tools and research platforms that complement its consulting services in health economics, outcomes research, real-world evidence (RWE), and market access. The core technology products include: Q-tracker (Power BI-based interactive visualization), Qfront (cloud-based web application platform connecting Excel-based economic models to web apps), Qmodel (free generic Excel-based oncology cost-effectiveness model), Qniform (proprietary common data model for cross-Nordic RWE data harmonization), and Quantify Data Explorer (R Shiny-based epidemiological data visualization tool). The company also maintains disease-specific RWD platforms for asthma (NORDSTAR), cardiovascular disease, chronic liver disease (HERALD), Parkinson's disease (Q-PARK), and psoriasis/psoriatic arthritis (Q-PsO/Q-PsA), along with a full suite of service offerings covering economic modelling, market access strategy, evidence review and synthesis, medical writing, and medical device support.

Product and service16 records
1Modelling, Access & Strategy
CategoryHEOR consulting service
2Real-World Evidence & Analytics
CategoryReal-world evidence service
3Evidence Review & Synthesis
CategoryEvidence synthesis service
4Medical Writing and Editorial Support
CategoryMedical writing service
5Medical Devices (MedTech & Digital Health)
CategoryMedTech consulting service
6Q-tracker
CategoryProprietary software tool
7Qfront
CategoryProprietary software tool
8Qmodel
CategoryProprietary software tool
9Qniform
CategoryProprietary software platform
10Quantify Data Explorer
CategoryProprietary software tool
11NORDSTAR (Nordic Dataset for Asthma Research)
CategoryDisease-specific research platform
12Cardiovascular Disease Research Platform
CategoryDisease-specific research platform
13HERALD (HEalth outcomes and Risk Assessment in chronic Liver Disease)
CategoryDisease-specific research platform
14Q-PARK (Quantify Parkinson's Research Programme)
CategoryDisease-specific research platform
15Q-PsO and Q-PsA (Psoriasis and Psoriatic Arthritis Platforms)
CategoryDisease-specific research platform
16Oncology Research Platform (Solid Tumor & Hematologic)
CategoryDisease-specific research platform
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Partnership on publication 'Economic Impact of Timely Systemic Treatment of Psoriatic Disease in Comorbidity Risk Reduction' published in Dermatology and Therapy.

2HERALD (Karolinska University Hospital and Karolinska Institutet)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Swedish collaborative research programme on chronic liver disease including several data sources linked on patient level. Led by Oskar Ström and Emilie Toresson Grip. Planned to generate quality research between 2021-2026.

quantifyresearch.com
3NORDSTAR (Nordic Dataset for Asthma Research)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cross-border multi-party collaboration between Nordic clinical asthma experts, Quantify Research, and pharmaceutical industry. Aims to improve understanding of burden of severe asthma and potential for improving patient prognosis. Currently comprises 3+ million asthma patients across Finland, Denmark, Norway, and Sweden.

quantifyresearch.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Project designed to provide a foundation for an integrated data environment and framework for real-world evidence research within Alzheimer's disease.

5International Osteoporosis Foundation (IOF)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Global alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone, muscle and joint health.

quantifyresearch.com
6IPECAD
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Forum for the value demonstration of Alzheimer interventions. Anders Gustavsson from Quantify sits in the steering committee and has co-developed an open-source cost-effectiveness model for AD.

quantifyresearch.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO with substantial real-world evidence and HEOR capabilities following the PRA Health Sciences acquisition. Competes with Quantify for biopharma outcomes research and market access work, but at meaningfully greater scale.

TypeBroad incumbent
Description

Largest global CRO and life sciences data services provider with broad HEOR, RWE, and market access practices. Competes with Quantify for pharma HEOR mandates but offers a much wider service portfolio and global delivery footprint.

TypeEmerging player
Description

Tech-led RWE analytics company used by pharma and regulators for evidence generation. Competes with Quantify for RWE mandates, particularly those requiring analytics-platform-driven approaches, but lacks the Nordic registry depth that Quantify offers.

TypeDirect peer
Description

HEOR, real-world evidence, and patient-centered outcomes consultancy within RTI International. Comparable in service offering — economic modelling, systematic reviews, RWE for pharma and medical devices — but with a broader therapeutic and geographic footprint.

TypeDirect peer
Description

Statistical and HEOR consulting firm with biostatistics, real-world evidence, and market access offerings to pharma. Comparable to Quantify in the biostatistics and evidence-generation layer, with somewhat larger scale and broader therapeutic coverage.

TypeEmerging player
Description

Roche-owned oncology-focused real-world data and evidence company. Overlaps with Quantify's Oncology Research Platform work, particularly on cancer epidemiology and outcomes, though Flatiron's data depth is concentrated in US oncology EHR sources rather than Nordic registries.

TypeDirect peer
Description

Pure-play HEOR, real-world evidence, and market access consulting firm (owned by PPD, part of Thermo Fisher). Most directly comparable to Quantify in terms of service mix — economic modelling, RWE, evidence synthesis — but operates at significantly greater global scale.

TypeDirect peer
Description

HEOR and market access consultancy serving pharma clients (Puneet Kaushik, Quantify's India Country Director, previously worked at BresMed). Very close comparable in team size, service mix (economic modelling, evidence review), and pharma-segment focus.

TypeBroad incumbent
Description

Major global CRO with HEOR and real-world evidence capabilities. Quantify's CEO Kirk Geale previously held an HEOR role at Parexel, reflecting the talent pipeline overlap and the direct competition for pharma HEOR/RWE engagements.

TypeBroad incumbent
Description

Health services, data, and consulting arm of UnitedHealth Group with significant real-world evidence and HEOR capabilities. Competes with Quantify for pharma evidence-generation work and benefits from very large US claims/EHR data assets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quantify Research

Health Economics & Outcomes Research Consultingquantifyresearch.com

Quantify Research is a Stockholm-based HEOR consultancy providing health economic modelling, real-world evidence, and market access services to pharmaceutical, medical device, government, and academic clients, leveraging proprietary access to Nordic registry data covering ~26 million inhabitants and a portfolio of in-house analytics software tools.

What Quantify Research does

Quantify Research is a privately held health economics and outcomes research (HEOR) consultancy founded in 2011 in Stockholm, Sweden, now operating as part of the Athagoras Group. The company delivers health economic modelling, real-world evidence generation, market access strategy, evidence review and synthesis, and medical writing services to large pharmaceutical companies, medical device manufacturers, government bodies, and academic institutions across Europe and North America. Its core differentiator is access to Nordic administrative and disease-specific registries providing population-level coverage of approximately 26 million inhabitants across Sweden, Denmark, Norway, and Finland, with the ability to link patient-level data across primary care, hospitalizations, prescriptions, socioeconomics, labs, EHRs, and PROMs. Quantify maintains disease-specific research platforms in asthma (NORDSTAR, covering 3 million+ patients), cardiovascular disease, chronic liver disease (HERALD, with Karolinska Institutet), Parkinson's disease, psoriasis/psoriatic arthritis, and oncology.

Quantify Research operates a portfolio of proprietary software tools built on top of this data and consulting expertise. These include Qniform (a proprietary common data model for cross-Nordic data harmonization and validation), Q-tracker (a Power BI-based interactive visualization and analysis tool), Qfront (a cloud-based web application platform that converts Excel-based health economic models into interactive multi-user web apps), Qmodel (a free, generic Excel-based cost-effectiveness model for oncology), and Quantify Data Explorer (an R Shiny-based epidemiological visualization tool). The company combines 50% PhD-level talent with active academic affiliations to Karolinska Institutet, holds a track record of 200+ completed observational data projects and 100+ peer-reviewed publications, and reports data access turnarounds as short as two weeks.

The business model is professional services revenue generated through quote-based B2B engagements, augmented by productized software and disease-specific data platforms that support reuse across pharma accounts. Quantify operates from offices in Stockholm (headquarters), Copenhagen, Helsinki, Oslo, and Chandigarh (via wholly-owned subsidiary Quantify HEOR Private Limited), with a 11-50 employee base. Distribution is primarily enterprise direct sales supplemented by scientific-community marketing through ISPOR, EASL, EHA, Eurospine, and similar conferences, alongside an active peer-reviewed publication program that drives inbound enterprise interest. No external funding rounds are disclosed.

Quantify Research firmographics

Firmographics
Name
Quantify Research
Legal name
Quantify Research AB
Website
https://quantifyresearch.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
51–100 employees
Short description
Quantify Research is a Stockholm-based HEOR consultancy providing health economic modelling, real-world evidence, and market access services to pharmaceutical, medical device, government, and academic clients, leveraging proprietary access to Nordic registry data covering ~26 million inhabitants and a portfolio of in-house analytics software tools.
Ownership category
akta.pro rank

Quantify Research industry classification

Industry
Product category
Health Economics & Outcomes Research Consulting
NAICS
Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAJANAM
Data Linkage, Registries & Longitudinal Cohort Surveillance
SECONDARYHLACAIAE
Healthcare Data Quality, Profiling & Observability
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAHAC
Quality Measurement, Reporting & Benchmarking (HEDIS/Stars/CQM)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics

Keywords

  • Health economics consulting
  • Real-world evidence
  • Market access services
  • Outcomes research
  • Pharmaceutical analytics

Where Quantify Research is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices5 records

Markets served

Quantify Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Health Economics & Outcomes Research Consultancy: Professional services revenue generated through consulting engagements with pharmaceutical companies, biotech firms, healthcare organizations, and government bodies. Services include economic modelling, evidence generation, market access strategy, and biostatistics analysis.
  2. Real-World Evidence Studies: RWE generation services using Nordic registry data for clinical, economic, and regulatory decision-making purposes across product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Quantify Research product offering

Product offering

Core offering

Quantify Research is a health economics and outcomes research consultancy that delivers health economic modelling, Nordic market access strategy, real-world evidence generation from Nordic registries, evidence review and synthesis, and medical writing for pharmaceutical, biotech, medical device, and government clients. The firm complements its consulting services with proprietary software (Qniform, Q-tracker, Qfront, Qmodel, Quantify Data Explorer) and disease-specific real-world data platforms covering asthma, cardiovascular disease, chronic liver disease, Parkinson's disease, psoriasis, and oncology.

Product overview

Quantify Research offers a portfolio of software tools and research platforms that complement its consulting services in health economics, outcomes research, real-world evidence (RWE), and market access. The core technology products include: Q-tracker (Power BI-based interactive visualization), Qfront (cloud-based web application platform connecting Excel-based economic models to web apps), Qmodel (free generic Excel-based oncology cost-effectiveness model), Qniform (proprietary common data model for cross-Nordic RWE data harmonization), and Quantify Data Explorer (R Shiny-based epidemiological data visualization tool). The company also maintains disease-specific RWD platforms for asthma (NORDSTAR), cardiovascular disease, chronic liver disease (HERALD), Parkinson's disease (Q-PARK), and psoriasis/psoriatic arthritis (Q-PsO/Q-PsA), along with a full suite of service offerings covering economic modelling, market access strategy, evidence review and synthesis, medical writing, and medical device support.

Differentiator

Problem solved

Functional benefit

Products and services

  • Modelling, Access & Strategy
  • Real-World Evidence & Analytics
  • Evidence Review & Synthesis
  • Medical Writing and Editorial Support
  • Medical Devices (MedTech & Digital Health)
  • Q-tracker
  • Qfront
  • Qmodel
  • Qniform
  • Quantify Data Explorer
  • NORDSTAR (Nordic Dataset for Asthma Research)
  • Cardiovascular Disease Research Platform
  • HERALD (HEalth outcomes and Risk Assessment in chronic Liver Disease)
  • Q-PARK (Quantify Parkinson's Research Programme)
  • Q-PsO and Q-PsA (Psoriasis and Psoriatic Arthritis Platforms)
  • Oncology Research Platform (Solid Tumor & Hematologic)

Quantifiable outcome

  • 200+ observational data projects completed
  • +3 more outcomes

Companies that use Quantify Research

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Quantify Research technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Quantify Research partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • IFPA (International Federation of Psoriasis Associations)minorStrategic or Co-development Partner · 1 January 2026Partnership on publication 'Economic Impact of Timely Systemic Treatment of Psoriatic Disease in Comorbidity Risk Reduction' published in Dermatology and Therapy.
  • HERALD (Karolinska University Hospital and Karolinska Institutet)coreStrategic or Co-development Partner · 1 January 2021Swedish collaborative research programme on chronic liver disease including several data sources linked on patient level. Led by Oskar Ström and Emilie Toresson Grip. Planned to generate quality research between 2021-2026.
  • NORDSTAR (Nordic Dataset for Asthma Research)coreStrategic or Co-development PartnerCross-border multi-party collaboration between Nordic clinical asthma experts, Quantify Research, and pharmaceutical industry. Aims to improve understanding of burden of severe asthma and potential for improving patient prognosis. Currently comprises 3+ million asthma patients across Finland, Denmark, Norway, and Sweden.
  • IMI ROADMAPminorStrategic or Co-development PartnerProject designed to provide a foundation for an integrated data environment and framework for real-world evidence research within Alzheimer's disease.
  • International Osteoporosis Foundation (IOF)minorStrategic or Co-development PartnerGlobal alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone, muscle and joint health.
  • IPECADminorStrategic or Co-development PartnerForum for the value demonstration of Alzheimer interventions. Anders Gustavsson from Quantify sits in the steering committee and has co-developed an open-source cost-effectiveness model for AD.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Quantify Research competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: Global CRO with substantial real-world evidence and HEOR capabilities following the PRA Health Sciences acquisition. Competes with Quantify for biopharma outcomes research and market access work, but at meaningfully greater scale.
  • IQVIA: Largest global CRO and life sciences data services provider with broad HEOR, RWE, and market access practices. Competes with Quantify for pharma HEOR mandates but offers a much wider service portfolio and global delivery footprint.
  • Parexel International: Major global CRO with HEOR and real-world evidence capabilities. Quantify's CEO Kirk Geale previously held an HEOR role at Parexel, reflecting the talent pipeline overlap and the direct competition for pharma HEOR/RWE engagements.
  • Optum Insight: Health services, data, and consulting arm of UnitedHealth Group with significant real-world evidence and HEOR capabilities. Competes with Quantify for pharma evidence-generation work and benefits from very large US claims/EHR data assets.

Emerging players

  • Aetion: Tech-led RWE analytics company used by pharma and regulators for evidence generation. Competes with Quantify for RWE mandates, particularly those requiring analytics-platform-driven approaches, but lacks the Nordic registry depth that Quantify offers.
  • Flatiron Health: Roche-owned oncology-focused real-world data and evidence company. Overlaps with Quantify's Oncology Research Platform work, particularly on cancer epidemiology and outcomes, though Flatiron's data depth is concentrated in US oncology EHR sources rather than Nordic registries.

Direct peers

  • RTI Health Solutions: HEOR, real-world evidence, and patient-centered outcomes consultancy within RTI International. Comparable in service offering — economic modelling, systematic reviews, RWE for pharma and medical devices — but with a broader therapeutic and geographic footprint.
  • Cytel: Statistical and HEOR consulting firm with biostatistics, real-world evidence, and market access offerings to pharma. Comparable to Quantify in the biostatistics and evidence-generation layer, with somewhat larger scale and broader therapeutic coverage.
  • Evidera: Pure-play HEOR, real-world evidence, and market access consulting firm (owned by PPD, part of Thermo Fisher). Most directly comparable to Quantify in terms of service mix — economic modelling, RWE, evidence synthesis — but operates at significantly greater global scale.
  • BresMed: HEOR and market access consultancy serving pharma clients (Puneet Kaushik, Quantify's India Country Director, previously worked at BresMed). Very close comparable in team size, service mix (economic modelling, evidence review), and pharma-segment focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Quantify Research social profiles

Digital presence

Quantify Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quantify Research leadership team

Management profile

Number of profiles

Profiles9 records

Quantify Research subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Quantify Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quantify Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quantify Research

What does Quantify Research do?

Quantify Research is a health economics and outcomes research consultancy that delivers health economic modelling, Nordic market access strategy, real-world evidence generation from Nordic registries, evidence review and synthesis, and medical writing for pharmaceutical, biotech, medical device, and government clients. The firm complements its consulting services with proprietary software (Qniform, Q-tracker, Qfront, Qmodel, Quantify Data Explorer) and disease-specific real-world data platforms covering asthma, cardiovascular disease, chronic liver disease, Parkinson's disease, psoriasis, and oncology.

Is Quantify Research a public or private company?

Quantify Research is a private company. It is classified as corporate owned and is currently operating.

When was Quantify Research founded?

Quantify Research was founded in 2011. It employs 51 to 100 people.

Where is Quantify Research based?

Quantify Research is headquartered in Stockholm, Sweden, in the Europe region.

How does Quantify Research make money?

Two revenue lines are on record. Health Economics & Outcomes Research Consultancy is the primary driver. The others are real-World Evidence Studies.

Who are Quantify Research's main competitors?

Broad incumbents on record are ICON plc, IQVIA, Parexel International and Optum Insight. Emerging players are Aetion and Flatiron Health. Direct peers are RTI Health Solutions, Cytel, Evidera and BresMed.

Does Quantify Research have an API?

No public API is recorded for Quantify Research.

What industry is Quantify Research in?

Quantify Research's product category is Health Economics & Outcomes Research Consulting. Its primary akta.pro industry code is BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics, with a secondary code of HLAJANAM, Data Linkage, Registries & Longitudinal Cohort Surveillance. Its NAICS code is 54169 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales